Last edition
News about Global Pharma
The agreement was facilitated by the NS Pharma Innovation Research Partnering (IRP) team, located in Cambridge, MA.
Global Pharma | 05/04/2024 | By Manvi | 332
Clario Acquires ArtiQ to Boost AI Use in Clinical Trials
Clario has recently acquired ArtiQ, an innovative software company dedicated to enhancing the diagnosis and monitoring of patients with respiratory conditions.
Global Pharma | 05/04/2024 | By Aishwarya | 810
Alterome Therapeutics Bags USD 132 Million in Series B Financing
Alterome Therapeutics, Inc. has announced the closing of a USD 132 million Series B financing.
Global Pharma | 05/04/2024 | By Aishwarya | 522
Shimadzu Medical Systems USA Acquires California X-ray Imaging Services
CIS, headquartered in Vacaville, CA, has been a trusted provider of medical imaging products and services since 1992, serving the northern California and northern Nevada regions.
Global Pharma | 05/04/2024 | By Abha | 659
Lupin Appoints Dr. Ranjana Pathak as Chief Quality Officer
Bringing over three decades of industry experience to her new role, Dr. Pathak will lead Lupin's quality and regulatory compliance efforts across its global operations.
Global Pharma | 05/04/2024 | By Abha | 705
Bharat Biotech Partners with Bilthoven Biologicals for Oral Polio Vaccines
Bharat Biotech has teamed up with Bilthoven Biologicals, a subsidiary of Serum Institute of India to produce and supply oral polio vaccines (OPVs) worldwide.
Global Pharma | 05/04/2024 | By Aishwarya | 777
Stevanato Group Appoints Ugo Gay as Chief Operations Officer
Stevanato Group S.p.A. announced the appointment of Ugo Gay as its new Chief Operations Officer (COO).
Global Pharma | 04/04/2024 | By Manvi | 173
Cadenza Bio Welcomes Michael A. Panzara to its Board of Directors
Cadenza Bio, Inc. has appointed Michael A. Panzara, MD, MPH, to its esteemed board of directors.
Global Pharma | 04/04/2024 | By Aishwarya | 998
TC BioPharm to Boost Treatment Capacity and Slash Costs with Advanced Manufacturing Process
The company's initiative aims to leverage its existing infrastructure to scale up production dramatically, projecting a surge from 52 patient treatments annually to over 1,000.
Global Pharma | 04/04/2024 | By Abha | 658
The acquisition is expected to accelerate Apotex's growth within the specialty branded pharmaceutical market, adding a diverse portfolio of over 60 products and a full-service branded pharmaceutical platform.
Global Pharma | 04/04/2024 | By Abha | 1293
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy